Keiko Kobayashi
- Clinical Biochemistry top 1%
- Metabolism and Genetic Disorders 30
- Infectious Diseases top 2%
- Clostridium difficile and Clostridium perfringens research 41
- Antimicrobial Resistance in Staphylococcus 13
- Immunology top 5%
- Toxin Mechanisms and Immunotoxins 24
- Biochemistry top 5%
- Amino Acid Enzymes and Metabolism 18
- Hematology top 5%
-
- Streptococcal Infections and Treatments 18
-
- Botulinum Toxin and Related Neurological Disorders 12
-
- Biochemical effects in animals 7
Keiko Kobayashi
189 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 143
- Clinical Biochemistry 425
- Infectious Diseases 667
- Immunology 718
- Biochemistry 175
- Hematology 229
Countries citing papers authored by Keiko Kobayashi
This map shows the geographic impact of Keiko Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Kobayashi more than expected).
Fields of papers citing papers by Keiko Kobayashi
This network shows the impact of papers produced by Keiko Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Kobayashi. The network helps show where Keiko Kobayashi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keiko Kobayashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2017 | 9 | |
| 6 | 2013 | 27 | |
| 7 | 2013 | 1 | |
| 8 | 2010 | 1 | |
| 9 | 2009 | 4 | |
| 10 | 2009 | 0 | |
| 11 | Overview of Citrin Deficiency:SLC25A13 Mutations and the Frequency | 2008 | 10 |
| 12 | A case of adult-onset type II citrullinemia in which oral administration of L-Arginine Granules improved the patient's encephalopathy and the increased level of serum ammonia | 2002 | 3 |
| 13 | 2002 | 8 | |
| 14 | 2000 | 1 | |
| 15 | 2000 | 0 | |
| 16 | 2000 | 1 | |
| 17 | 2000 | 15 | |
| 18 | 1999 | 22 | |
| 19 | 1995 | 2 | |
| 20 | 1991 | 36 |
About Keiko Kobayashi
Keiko Kobayashi is a scholar working on Clinical Biochemistry, Biochemistry and Infectious Diseases, having authored 204 papers that have together received 3.4k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (41 papers), Metabolism and Genetic Disorders (30 papers), Toxin Mechanisms and Immunotoxins (24 papers), Streptococcal Infections and Treatments (18 papers), Amino Acid Enzymes and Metabolism (18 papers), Antimicrobial Resistance in Staphylococcus (13 papers), Botulinum Toxin and Related Neurological Disorders (12 papers) and Biochemical effects in animals (7 papers). The work is most often cited by research in Clinical Biochemistry (425 citations), Infectious Diseases (667 citations) and Immunology (718 citations). Keiko Kobayashi has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Masahiro Nagahama, Jun Sakùrai, Nobuhiko Katunuma, Masaya Takehara, Masataka Oda, Teruhisa Takagishi, Soshi Seike, Takeyori Saheki, Yoshitaka Hamaguchi and Kazuaki Miyamoto. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.